These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 13392574)

  • 1. [Micromethod in determination of antimony in blood and urine in visceral leishmaniasis during solusurmin therapy].
    LAPIN LN
    Vopr Med Khim; 1956; 2(4):309-15. PubMed ID: 13392574
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of infantile visceral leishmaniasis with solusurmin according to material of the parasitological department of the Tashkent City Sanitary-Epidemiological Station].
    MIKHAILOV VG; STARTSEVA MA
    Med Parazitol (Mosk); 1961; 30():563-7. PubMed ID: 14473694
    [No Abstract]   [Full Text] [Related]  

  • 3. [METABOLISM OF ANTIMONY IN CHILDREN WITH VISCERAL LEISHMANIASIS TREATED WITH SOLUSURMIN. II].
    FUZAILOV IuM
    Med Parazitol (Mosk); 1964; 33():438-43. PubMed ID: 14250146
    [No Abstract]   [Full Text] [Related]  

  • 4. [The level of antimony in dogs with visceral leishmaniasis treated with solusurmin].
    FUZAILOV IuM
    Med Parazitol (Mosk); 1962; 31():723-7. PubMed ID: 13945955
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antimony resistance in the treatment of visceral leishmaniasis].
    MIRZOIAN NA
    Med Parazitol (Mosk); 1957; 26(3):277-80. PubMed ID: 13482777
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of visceral leishmaniasis with solusurmin in children].
    KARAKHODZHAEV BKh
    Pediatriia; 1953; 4():60-1. PubMed ID: 13088230
    [No Abstract]   [Full Text] [Related]  

  • 7. [Autochthonous kala-azar (visceral leishmaniasis); treatment with antimonial derivatives].
    WILDE H; DI CARLO FC; PESSAT OA
    Rev Med Cordoba; 1956 Sep; 44():319-31. PubMed ID: 13420979
    [No Abstract]   [Full Text] [Related]  

  • 8. [Autochthonous kala-azar (visceral leishmaniasis); treatment with antimonial derivatives: personal observation].
    DI CARLO FC; PESSAT OA; WILDE H
    Dia Med; 1956 Nov; 28(84):2629-31; passim. PubMed ID: 13397380
    [No Abstract]   [Full Text] [Related]  

  • 9. [Toxic nephritis during the course of antimony treatment of kala-azar].
    BOUDIN G; PEPIN B; MORIN
    Concours Med; 1957 Jun; 79(24):2927-9. PubMed ID: 13447377
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunochemotherapy of visceral leishmaniasis: a pilot trial of sequential treatment with recombinant interferon-gamma and pentavalent antimony.
    Harms G; Zwingenberger K; Sandkamp B; Omena S; Pedrosa C; Richter J; Rosenkaimer F; Feldmeier H; Bienzle U
    J Interferon Res; 1993 Feb; 13(1):39-41. PubMed ID: 8454909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of recombinant gamma interferon associated with pentavalent antimony in therapy for visceral leishmaniasis.
    Badaro R
    Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():376-7. PubMed ID: 3151000
    [No Abstract]   [Full Text] [Related]  

  • 12. [Azotemic nephritis during antimony therapy of a case of infantile visceral leishmaniasis].
    CHARLAS R; BENABADJI A
    Maroc Med; 1962 Dec; 41():1180-2. PubMed ID: 14020224
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of the sweat glands in excreting antimony from the body in people living in the biogeochemical provinces of the Fergana Valley].
    Fuzaĭlov IuM
    Gig Tr Prof Zabol; 1992; (5):13-5. PubMed ID: 1427342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 10 receptor blockade--pentavalent antimony treatment in experimental visceral leishmaniasis.
    Murray HW
    Acta Trop; 2005 Mar; 93(3):295-301. PubMed ID: 15716043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secretion of antimony and stilbamidine in the treatment of visceral leishmaniasis in children].
    MIKHAILOV VG
    Farmakol Toksikol; 1959; 22(2):175-8. PubMed ID: 13653152
    [No Abstract]   [Full Text] [Related]  

  • 16. Visceral leishmaniasis therapy.
    Cascio G; Titone L
    J Chemother; 1989 Jul; 1(4 Suppl):956-9. PubMed ID: 16312721
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of splenectomy in HIV-infected patients with relapsing visceral leishmaniasis.
    Troya J; Casquero A; Muñiz G; Fernández-Guerrero ML; Górgolas M
    Parasitology; 2007 May; 134(Pt 5):621-4. PubMed ID: 17156583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
    Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G
    Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of visceral leishmaniasis in adults].
    MIRZOIAN NA
    Sov Med; 1957 Sep; 21(9):113-7. PubMed ID: 13519249
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis and treatment of Indian visceral leishmaniasis.
    Sundar S; Benjamin B
    J Assoc Physicians India; 2003 Feb; 51():195-201. PubMed ID: 12725267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.